Update: COVID-19 - Changes for clinical trials
messages in brief | 17/03/2020
For changes necessary for ongoing clinical trials due to the COVID-19 pandemic, a separate area for clinical trials was created.
The FAQs will be updated and expanded on an ongoing basis. The first FAQ deals with the sending of study medication to study participants.
Further information on COVID-19 and clinical trials
Further inquiry note
Page last modified: 17/03/2020